Radical Hysterectomy: Multimedia

References

1. O'Dowd MJ, Philipp EE. The History of Obstetrics and Gynaecology. Vol 1. New York, NY: Parthenon Publishing Group; 1994:. 543-70.

2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. Jul-Aug 2009;59(4):225-49. [Medline]. [Full Text].

3. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. Apr 3 2001;164(7):1017-25. [Medline]. [Full Text].

4. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. Dec 21 1990;63(6):1129-36. [Medline].

5. Jones RE, Wegrzyn RJ, Patrick DR, et al. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. J Biol Chem. Aug 5 1990;265(22):12782-5. [Medline].

6. Hellberg D, Nilsson S, Haley NJ, et al. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol. Apr 1988;158(4):910-3. [Medline].

7. Brinton LA, Huggins GR, Lehman HF, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer. Sep 15 1986;38(3):399-44. [Medline].

8. Beral V, Hannaford P, Kay C. Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners'' Oral Contraception Study. Lancet. Dec 10 1988;2(8624):1331-5. [Medline].

9. Campion MJ. Preinvasive Disease. In: Berek JS, Hacker NF. Practical Gynecologic Oncology. 4th ed. 2005:265-336.

10. Howley PM. Role of the human papillomaviruses in human cancer. Cancer Res. Sep 15 1991;51(18 Suppl):5019s-5022s. [Medline].

11. Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol. Nov 2009;201(5):485.e1-9. [Medline].

12. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. Jan 1999;17(1):41-5. [Medline].

13. Lai CH, Yen TC, Ng KK. Surgical and radiologic staging of cervical cancer. Curr Opin Obstet Gynecol. Feb 2010;22(1):15-20. [Medline].

14. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. Jan 1999;64(1):5-10. [Medline].

15. Fanfani F, Fagotti A, Ferrandina G, Raspagliesi F, Ditto A, Cerrotta AM, et al. Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome. Int J Gynecol Cancer. Aug 2009;19(6):1119-24. [Medline].

16. Patsner B. Radical abdominal hysterectomy using the ENDO-GIA stapler: report of 150 cases and literature review. Eur J Gynaecol Oncol. 1998;19(3):215-9. [Medline].

17. Cibula D, Velechovska P, Sláma J, Fischerova D, Pinkavova I, Pavlista D, et al. Late morbidity following nerve-sparing radical hysterectomy. Gynecol Oncol. Nov 9 2009;[Medline].

18. Skret-Magierlo J, Naróg M, Kruczek A, Kluza R, Kluz T, Magon T, et al. Radical hysterectomy during the transition period from traditional to nerve-sparing technique. Gynecol Oncol. Dec 9 2009;[Medline].

19. Lowe MP, Chamberlain DH, Kamelle SA, Johnson PR, Tillmanns TD. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer. Gynecol Oncol. May 2009;113(2):191-4. [Medline].

20. Roy M, Plante M. Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer. Am J Obstet Gynecol. Dec 1998;179(6 Pt 1):1491-6. [Medline].

21. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. Apr 15 1999;340(15):1154-61. [Medline].

22. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. Apr 15 1999;340(15):1144-53. [Medline].

23. Alvarez RD, Soong SJ, Kinney WK, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early- stage squamous carcinoma of the cervix. Gynecol Oncol. Nov 1989;35(2):130-5. [Medline].

24. Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. J Epidemiol Biostat. 2001;6(1):7-43. [Medline].

25. Brewer CA, Chan J, Kurosaki T, Berman ML. Radical hysterectomy with the endoscopic stapler. Gynecol Oncol. Oct 1998;71(1):50-2. [Medline].

26. Creasman WT, Zaino RJ, Major FJ, et al. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol. Jan 1998;178(1 Pt 1):62-5. [Medline].

27. Fanning J, Kraus K. Surgical stapling technique for radical hysterectomy: survival, recurrence, and late complications. Gynecol Oncol. Nov 2000;79(2):281-3. [Medline].

28. Fuller AF Jr, Elliott N, Kosloff C, Lewis JL Jr. Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment. Gynecol Oncol. Apr 1982;13(2):165-74. [Medline].

29. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. Jan-Feb 2001;51(1):15-36. [Medline].

30. Hacker NF. Cervical Cancer. In: Berek JS, Hacker NF. Practical Gynecologic Oncology 4th ed. 2005;337 - 396.

31. Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol. May 1998;178(5):971-6. [Medline].

32. Janicek MF, Averette HE. Cervical cancer: prevention, diagnosis, and therapeutics. CA Cancer J Clin. Mar-Apr 2001;51(2):92-114; quiz 115-8. [Medline].

33. Kilgore LC, Orr JW Jr, Hatch KD, et al. Peritoneal cytology in patients with squamous cell carcinoma of the cervix. Gynecol Oncol. Sep 1984;19(1):24-9. [Medline].

34. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. Aug 23 1997;350(9077):535-40. [Medline].

35. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. Apr 15 1999;340(15):1137-43. [Medline].

36. Orr JW Jr. Cervical cancer. Surg Oncol Clin N Am. Apr 1998;7(2):299-316. [Medline].

37. Orr JW Jr, Orr PJ, Bolen DD, Holimon JL. Radical hysterectomy: does the type of incision matter?. Am J Obstet Gynecol. Aug 1995;173(2):399-405; discussion 405-6. [Medline].

38. Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. Apr 2000;18(8):1606-13. [Medline].

39. Possover M, Stober S, Plaul K, Schneider A. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. Nov 2000;79(2):154-7. [Medline].

40. Randall ME, Michael H, Vermorken J. Uterine Cervix. In: Hoskins WJ, Perez CA, Young RC, et al. Principles and Practice of Gynec. 2005;743-822.

41. Roy M, Plante M, Renaud MC, Tetu B. Vaginal radical hysterectomy versus abdominal radical hysterectomy in the treatment of early-stage cervical cancer. Gynecol Oncol. Sep 1996;62(3):336-9. [Medline].

42. Scheidler J, Hricak H, Yu KK, et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA. Oct 1 1997;278(13):1096-101. [Medline].

43. Shingleton HM, Orr JW. Historical aspects, pathogenesis, and epidemiology. In: Shingleton HM, Orr JW, eds. Cancer of the Cervix: A Clinical Approach. 1st ed. Philadelphia, Pa: Lippincott-Raven; 1995:. 1-15.

44. Shingleton HM, Orr JW. Screening. In: Cancer of the Cervix: A Clinical Approach. 1st ed. Lippincott-Raven;1995:16-33.

45. Spirtos NM, Schlaerth JB, Kimball RE, et al. Laparoscopic radical hysterectomy (type III) with aortic and pelvic lymphadenectomy. Am J Obstet Gynecol. Jun 1996;174(6):1763-7; discussion 1767-8. [Medline].

46. Tarraza HM, Ellerkmann RM. Pelvic radical surgery. Surg Oncol Clin N Am. Apr 1998;7(2):399-416. [Medline].

47. Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. May-Jun 2001;11(3):180-6. [Medline].

48. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. May 1999;17(5):1339-48. [Medline].

49. Whitney CW, Stehman FB. The abandoned radical hysterectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. Dec 2000;79(3):350-6. [Medline].

Further Reading

Keywords

type III radical hysterectomy, Meigs hysterectomy, modified radical hysterectomy, Wertheim radical hysterectomy, pelvic lymphadenectomy, cervical cancer, cervical carcinoma, squamous cell carcinoma, SCC, adenocarcinoma, human papillomavirus, HPV, nicotine, cotinine, oral contraceptives, abnormal vaginal discharge, abnormal vaginal bleeding, postcoital bleeding, postcoital spotting, hysterectomy, total hysterectomy, cancer of the cervix, cigarette smoking, smoking, malodorous vaginal discharge, FIGO staging, FIGO classification

Contributor Information and Disclosures

Author

Michael J Sundborg, MD, FACOG, Assistant Professor, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, F Hebert School of Medicine; Chief and Principle Investigator, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brooke Army Medical Center
Michael J Sundborg, MD, FACOG is a member of the following medical societies: Alpha Omega Alpha, American Association of Gynecologic Laparoscopists, American College of Obstetricians and Gynecologists, American Medical Association, Association of Professors of Gynecology and Obstetrics, and Society of Gynecologist Oncologists
Disclosure: Nothing to disclose.

Coauthor(s)

Margarett C Ellison, MD, Consulting Staff, Kaiser Permanente, Los Angeles Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Jeffrey B Garris, MD, Chief, Assistant Professor, Department of Obstetrics and Gynecology, Division of Urogynecology and Reconstructive Pelvic Surgery, Tulane University School of Medicine
Jeffrey B Garris, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, American Urological Association, Association of Professors of Gynecology and Obstetrics, Louisiana State Medical Society, Royal Society of Medicine, and Sigma Xi
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Michel E Rivlin, MD, Professor, Coordinator of Quality Assurance/Quality Improvement, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine
Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, and Royal College of Surgeons of Edinburgh
Disclosure: Nothing to disclose.